Table 1 High-intensity focused ultrasound (HIFU) ablation studies treating fibroadenomata
From: A review of ablative techniques in the treatment of breast fibroadenomata
| Study | Number | Size (cm) | Age (years) | Device | Follow-up (months) | Therapeutic efficacy | Complications | Time (min) |
|---|---|---|---|---|---|---|---|---|
| Hynynen (2001) | 9 (11) | 1.9 ± 1.5 cm3 (0.7–6.5)a | 29 (19–38)b | InSightec (transducer diameter 100 mm and radius curvature 80 mm) | 6 (18–48) | Complete necrosis (n = 6), partial necrosis (n = 2), minor necrosis (n = 1) and no response (n = 2) | Oedema, tenderness | – |
| Tempany (2005) | 102 | – | – | InSightec (−) | – | – | – | – |
| Kovatcheva & Boulanger (2014) | 42 (51) | 3.9 ml (0.3–19.7)a | 32 (16–52)a | EchoPulse (transducer diameter 60 mm, 3 MHz) | 12 | Reduction of 33.2 ± 19.1 % at 2 months, 59.2 ± 18.2 % at 6 months and 72.5 ± 16.7 % at 12 months | Skin burn (n = 3), hyperpigmentation (n = 1) | 118 (60–255)a |
| Cavallo-Marincola (2014) | 10 | – | 26 (18–34)a | JC HIFU (−) | – | 50 % reduction after in maximum diameter after 3 months | Swelling, hardness of area | 57.2 (40–100)a |
| Hahn (2016) | 27 | – | – | EchoPulse (transducer diameter 60 mm, 3 MHz) | 12 | – | – | – |
| Douek (2016) | 50 | – | – | EchoPulse (transducer diameter 60 mm, 3 MHz) | 12 | – | – | |
| Brenin (2016) | 20 | – | – | EchoPulse (transducer diameter 60 mm, 3 MHz) | 12 | – | – |